S100A6 and hepatocellular carcinoma: As indicated in Figure 1a,the immunoblotting, based on the six pairs of the clinical samples, showed that thehuman HCC tissues presented an upregulation of S100A6 (T) compared with the adjacentnon-tumor liver tissues (N).